The following Structured Product Label (SPL) was submitted to the FDA by Pharmazeutische Fabrik Dr. Reckeweg & Co for the product Dr. Reckeweg R13 Prohaemorrhin (NDC 53346-1313). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.
This specific version of the label includes detailed information regarding otc - active ingredient, otc - purpose, indications & usage, warnings, otc - stop use, otc - pregnancy or breast feeding, otc - keep out of reach of children, dosage & administration, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.
Active ingredients
Aesculus hippocastanum 2X, Collinsonia canadensis 4X, Graphites 8X, Hamamelis viginiana 3X, Kali carbonicum 6X, Lycopodium clavatum 5X, Nitricum acidum 6X, Nux vomica 4X, Paeonia officinalis 3X, Sulphur 5X, 1 g each in 10 g.
Purpose
Relieves symptoms associated with hemorrhoids
Uses
For the temporary relief of minor symptoms associated with hemorrhoids:
Warnings
Stop use and ask a doctor if symptoms persist, get worse, or if new symptoms occur.
If pregnant or breastfeeding, ask a health care professional before use.
Keep out of reach of children.
Directions
Adults and children ≥ 12 years: acute cases: 5-10 drops up to a maximum of 6 times daily;
in chronic cases: 5-10 drops 3 times daily in a little water or undiluted or as recommended.
Other information
Inactive ingredients
Ethanol, purified water.
Image Of Carton Label (E002f75e 45f8 4b61 8772 0c3d10627e80)
NDC# 53346-1313-5
Dr. Reckeweg R13 Prohämorrhin
Homeopathic preparation for the temporary relief of minor symptoms associated with hemorrhoids:
Manufactured by:
Dr. Reckeweg Co. GmbH
D-64625 Bensheim
Germany
1.68 fl oz
(50 ml)
* Please review the disclaimer below.
